openPR Logo
Press release

Amyotrophic Lateral Sclerosis Treatment Market Size, Trends, Share, Forecast 2020-2026

08-04-2020 05:42 PM CET | Health & Medicine

Press release from: Orion Market Research

Amyotrophic Lateral Sclerosis Treatment Market

Amyotrophic Lateral Sclerosis Treatment Market

Global amyotrophic lateral sclerosis treatment market is anticipated to showcase a considerable CAGR during the forecast period (2020-2026). Amyotrophic lateral sclerosis disease is considered to be a disease of aging. People above the age of 65 are highly susceptible to the amyotrophic lateral sclerosis disease. According to the World Health Organization (WHO), the geriatric population is expected to get double by 2050, when compared to 2000. Globally, in 2000, the proportion of the people aged over 65 years were 11.0% of the global population, and these statistics are expected to reach 22.0% by 2050. In turn, the geriatric population is expected to reach 2 billion by 2050, as compared to 605 million in 2010.

Request a Free Sample of our Report on Amyotrophic Lateral Sclerosis Treatment Market: https://www.omrglobal.com/request-sample/amyotrophic-lateral-sclerosis-treatment-market

Similarly, the people aged over 80 years or older are expected to get quadrupled to 395 million from 2000 to 2050. According to the UN, over the next 15 years, the older population is expected to grow fastest in the Caribbean and Latin America with a projected 71.0% increase in the population aged 60 years or over, followed by Asia (66.0%), Africa (64.0%), Oceania (47.0%), Northern America (41.0%), and Europe (23.0%). In 2018, the global average geriatric population was 8.92%, in which, the percentage of geriatric population in developed economies was much higher than that of the global average (8.92%). In 2018, among the total population, the geriatric population accounted for 16.0% in North America, 22.0% in Germany, 23.0% in Italy, and 27.0% in Japan, among others.

The increasing prevalence of amyotrophic lateral sclerosis disorder along with the growing geriatric population which is more susceptible to this kind of disorders are expected to be key factors promoting the growth of the global amyotrophic lateral sclerosis treatment market. Mitsubishi Tanabe Pharma Corp., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., CORESTEM, Inc., BrainStorm Cell Ltd., Otsuka Pharmaceutical Co., Ltd., AB Science, Ionis Pharmaceuticals, Inc., Biohaven Pharmaceutical Holding Company Ltd., and so on are the key players operating in the global amyotrophic lateral sclerosis treatment industry.

A Full Report of Amyotrophic Lateral Sclerosis Treatment Market is Available at https://www.omrglobal.com/industry-reports/amyotrophic-lateral-sclerosis-treatment-market

Recent Development in Amyotrophic Lateral Sclerosis Treatment Market

• In September 2018, ITF Pharma, a US-based pharmaceutical company had received the US FDA approval for TIGLUTIK (riluzole). The TIGLUTIK (riluzole) is an oral suspension for the treatment of amyotrophic lateral sclerosis. TIGLUTIK is the first and only easy-to-swallow thickened riluzole liquid for treatment of amyotrophic lateral sclerosis and is advised to intake twice daily via an oral syringe.

Global Amyotrophic Lateral Sclerosis Market Segmentation

By Type
• Medication
• Stem Cell Therapy
• Others

Global Amyotrophic Lateral Sclerosis Market – Segment by Region

North America
• US
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World
• Middle East & Africa
• Latin America

Company Profiles
• AB Science
• Ascend Laboratories LLC
• Biogen Inc.
• Biohaven Pharmaceutical Holding Company Ltd.
• BrainStorm Cell Ltd.
• CORESTEM, Inc
• F.Hoffmann-La Roche AG
• Ionis Pharmaceuticals, Inc.
• ITF Pharma
• Mitsubishi Tanabe Pharma Corp.
• Mylan N.V.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/amyotrophic-lateral-sclerosis-treatment-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Amyotrophic Lateral Sclerosis Treatment Market Size, Trends, Share, Forecast 2020-2026 here

News-ID: 2103181 • Views:

More Releases from Orion Market Research

Sleep Apnea Implants Market Is Expected To Exhibit Significant Growth Over 2031
Sleep Apnea Implants Market Is Expected To Exhibit Significant Growth Over 2031
The global sleep apnea implants market is anticipated to grow at a CAGR of 10.6% during the forecast period. The rising geriatric population creating demand for global sleep apnea implants market during the forecast period. As per the study conducted by European Respiratory Society, the obstructive sleep apnea is a common disorder in older people; 13%-32% of people over 65 yrs old are highly susceptible to sleep apnea. According to
Radiofrequency ablation (RF) Devices Market Will Exhibit an Impressive Expansion by 2024-2031
Radiofrequency ablation (RF) Devices Market Will Exhibit an Impressive Expansion …
The global radiofrequency ablation devices market is anticipated to grow at a CAGR of 1.5% during the forecast period. The new and innovative RF ablation devices to support minimally invasive surgeries are a key factor driving the growth of the global radiofrequency ablation devices market. The key companies across the globe are highly inclined towards the adoption of different growth strategies including capacity expansion, mergers and acquisitions, new product launches,
Nasal Drug Delivery Market Is Expected To Exhibit Significant Growth Over 2031
Nasal Drug Delivery Market Is Expected To Exhibit Significant Growth Over 2031
The global nasal drug delivery market is anticipated to grow at a considerable CAGR of 5.5% during the forecast. The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace this is anticipated to positively impact significant market growth. A full report of Nasal
Myocardial Infarction Market Is Expected To Exhibit Significant Growth Over 2031
Myocardial Infarction Market Is Expected To Exhibit Significant Growth Over 2031
The global myocardial infarction market is anticipated to grow at a CAGR of around 6.6% during the forecast period. Factors contributing to the growth of the myocardial infarction market include rising incidence rate of CVDs (cardiovascular diseases) and intake of high-level sugary food, which significantly boost the prevalence of CADs (coronary artery diseases). According to the American Heart Association estimates, CVD is the leading global cause of death and accounted

All 5 Releases


More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986 Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications